Hodgkin's disease of nodular sclerosis and mixed cellularity subtypes is frequently associated with eosinophilia. To determine if interleukin-5 (IL-5) is implicated in producing the eosinophilia, w e performed in situ hybridization studies on cytopreparations of 16 cases of Hodgkin's disease with eosinophilia as well as cells from various controls. A single-stranded, anti-sense complementary DNA (cDNA) probe coding for a portion of the human IL-5 molecule was tail-labeled with digoxigenin -1 I-dUTP using terminal transferase, and then hybridized to messenger RNA (mRNA) within cells. An alkaline-phosphatase-conjugated antibody directed to digoxigenin was used with a chromogenic substrate to detect hybridized probe within cells. In all seven cases of nodular sclerosis subtype and nine cases of mixed cellularity subtype with eosinophilia, there was OSINOPHILS frequently infiltrate tissues involved by E Hodgkin's disease.' Although an eosinopoietic factor has been isolated from tumor extracts of carcinoma of the lung,2 there has been no explanation for the profound eosinophilia associated with Hodgkin's disease.
Among the factors implicated in eosinophil growth and differentiation are interleukin-5 (IL-5),5-* IL-2,9 IL-3," granulocyte-macrophage and colony-stimulating factor (GM-CSF)." Of these factors, IL-5 appears to be the most directly and specifically involved in eosinop~iesis.'~~'~ For example T cells from patients with eosinophilia have been shown to produce IL-5 after stimulation with IL-2. I6 In situ hybridization is a technique that identifies cells that contain messenger R N A (mRNA) encoding for a particular protein of interest. The assay is complementary to immunohistochemical procedures because it detects transcriptional activation of a gene. The objective of this study was to use a nonradioactive in situ hybridization technique to determine if mRNA encoding for IL-5 is present in Hodgkin's disease with eosinophilia. We present the interesting finding that mRNA encoding for IL-5 is strikingly localized to the cytoplasm of Reed-Sternberg cells and variants. This is the first report of IL-5 mRNA expressed in a human tumor associated with eosinophilia.
MATERIALS AND METHODS
Human cells and controls. The human cells used in this study were obtained from cryopreserved specimens maintained in the Hematopathology Cell Bank of the University of California at Irvine. Post-thaw viabilities of these cells were determined by measuring exclusion of trypan blue dye. Cells from all cases diagnosed as Hodgkin's disease of nodular sclerosis or mixed cellularity subtype were included in this study. Diagnoses were established by routine morphologic review of the tissue biopsies and are listed in Table 1 , along with a brief clinical summary of the patients. As negative controls, Sp 2/0 (murine myeloma) and IM-9 (human B-lymphocyte) cell lines (American Type Culture Committee, Rockville, MD) were used. In addition, cells from three normal spleens were included as controls because activated splenic T Louis, MO) and in glassware baked at 275OC for 6 hours to destroy RNase. Glass slides were washed in hot soapy water, rinsed well in distilled water, and air dried. The slides were then subbed in baked Coplinjars by incubating overnight in a solution of 250 mL of water containing 2.5 g of gelatin (Sigma) and 0.25 g of potassium chromate. The next morning, the slides were washed in distilled water and then rinsed in DEPC-treated water before being air dried and stored at -2OOC.
Cells used in the study were quickly thawed and washed twice in sterile Eppendorf tubes (2 mL) containing 500 pL of ice-cold phosphate buffered saline (PBS) with 0.1% bovine serum albumin (BSA) (Sigma) and 0.02% sodium azide. After washing, the cells were resuspended at a concentration of 2 x lo6 cells per milliliter of PBS-BSA-azide. Cytopreparations were prepared with a Shandon Cytospin 2 (Shandon Southern, Sewickley, PA), using 100 pL of cells in cytofunnels that had been presoaked in DEPC-treated water and air dried.
The cytopreparations were immediately fixed for 5 minutes in 3% paraformaldehyde prepared as follows. Paraformaldehyde (1 0%, methanol-free) (Polysciences, Warrington, PA) was diluted in PBS to a final concentration of 3% and then filtered through a 0.2 *m filter. Diethylpyrocarbonate (20 pL) was then added to 100 mL of the fixative immediately before fixation of the cytopreparations in Coplin jars. In cases with sufficient cells, some cytopreparations were also fixed without DEPC. In situ hybridization was performed directly after the slides were fixed and washed three times in PBS.
The single-stranded, anti-sense DNA probe for human IL-5 was obtained from Amgen Biologicals (Thousand Oaks, CA). Synthesized on an Applied Biosystems 380 DNA synthesizer and purified by polyacrylamide gel electrophoresis, the 30-base sequence was selected approximately one third of the distance from the 5' end and generated toward the 3' end of the gene coding for human IL-5 (Jim Chamberlain, Amgen, personal communication, August 1989).
The oligonucleotide probe was tail-labeled with digoxigenin-1 1 dUTP (Boehringer Mannheim Biochemicals, Indianapolis, IN) using terminal transferase (Boehringer). On ice, the following solutions were combined: 2.5 pL of 1OX tailing buffer (1.4 mmol/L potassium cacodylate, 300 mmol/L TRIS base at pH 7.2, 10 mmol/L cobalt chloride, 2 mmol/L dithiothreitol); 2.5 pL of 1 mmol/L digoxigenin-1 I-dUTP (Boehringer); 25 U of terminal transferase; 200 ng of probe in 5 WL distilled water; and 12 pL of DEPC-treated water. The reaction mixture was incubated at 37°C for 90 minutes and then frozen in 5 pL aliquots until use.
The procedures for in situ hybridization (including prehybridization, hybridization, post-hybridization, and immunologic detection) are described in detail in the Technical Update accompanying the Genius Nonradioactive DNA Labeling and Detection Kit (Boehringer). In brief, the cytopreparations were prehybridized in 2X saline-sodium citrate followed by a 1-hour incubation in prehybridization solution. All components of the solutions were obtained from Sigma, and the formamide was deionized with AG501-X8(D) mixed bed resin (Bio-Rad, Richmond, CA) before use. For the hybridization step, we used 50 pL of labeled probe per slide at a concentration of 60 pg/pL, and the slides were incubated overnight in a humidified chamber. As a negative control, slides from each case were also incubated in prehybridization solution without a labeled probe.
Post-hybridization was performed by sequential incubation of the slides in progressively more diluted saline-sodium citrate (final concentration OSX). For the immunologic detection, slides were preblocked in 2% normal sheep serum and then incubated for 2 hours IL-5 cDNA probe.
In situ hybridization.
with a 1500 dilution of polyclonal sheep anti-digoxigenin Fab fragments conjugated to alkaline phosphatase (Boehringer). The washed slides were then developed by incubation for 2 hours at room temperature in a solution of nitroblue tetrazolium and X-phosphate solution (Boehringer) in the presence of 2.4 mg levamisole (Sigma) to block endogenous alkaline phosphatase activity.
The color reaction was stopped with TRIS-EDTA, and the slides were then stained for 3 minutes in freshly filtered nuclear fast red stain. After a wash in distilled water, the slides were air dried and coverslipped with Permount (Fisher Scientific, Fairlawn, NJ) before microscopic examination.
RESULTS
There was no detectable binding of the labeled probe to the negative control cells (IM-9 and S p 2/0). When labeled probe was omitted from the hybridization procedure, there was no staining of the Reed-Sternberg cells from tissues containing Hodgkin's disease. Similarly, when the RNase inhibitor diethylpyrocarbonate was omitted from the procedure, Reed-Sternberg cells and variants from tissues involved with Hodgkin's disease had no or barely visible staining (Fig  1) . A case of mixed cellularity Hodgkin's disease without microscopic evidence of eosinophilia also had no visible binding of the probe to the Reed-Sternberg cells.
In cells obtained from three normal spleens, approximately 2% to 4% of the larger mononuclear cells had visible blue staining of the cytoplasm. As noted previously, two of these normal spleens were obtained from staging laparotomies of patients with nodular sclerosis Hodgkin's disease.
I n the remaining 16 cases of Hodgkin's disease with eosinophilia, there was striking localization of blue-gray staining in the cytoplasm of morphologically identifiable Reed-Sternberg cells and variants (Figs 2 through 6 ). Practically all of the larger cells had some visible staining, although there was variation in the staining intensity from cell to cell. Cases in which the cells had post-thaw viabilities less than 50% generally had weaker staining, Some cases had particularly intense staining of the ReedSternberg cells, and in those cyt rations, many of the adjacent small lymphocytes had purple nuclear and cytoplasmic staining. This possibly artifactual staining of the lymphocytes could be eliminated by adding a lZhour, posthybridization incubation in 50% formamide in PBS, which presumably increased the stringency of the hybridization. The staining intensity of Reed-Sternberg cells was not affected by the additional incubation, but there was deterioration in cellular morphology.
DISCUSSION
we demonstrated in a well-controll IL-5 mRNA in Reed-Sternberg Hodgkin's disease with eosinophilia. This is the first demonstration that IL-5 mRNA is expressed in a human tumor assoeiated with eosinophilia.
Our results may explain the prominent infiltration by eosinophils in many cases of Hodgkin's disease. If the mRNA coding for IL-5 is translated into IL-5 by the Reed-Sternberg cells, then tissues involved by Hodgkin's disease would be potent sources of eosinopoietic activity. We This study has also provided evidence of the power of nonisotopic in situ hybridization using a digoxigenin-labeled probe. In less than 2 days, it is possible to obtain easily interpreted hybridization studies, provided that the target cells are well-preserved and that strict procedures are used to eliminate RNase activity. The critical importance of the RNase inhibitor DEPC in this assay may be related to a recent report that eosinophil-derived neurotoxin and eosinophi cationic protein have potent ribonuclease a~tivity.~' Therefore, we conclude that nonradioactive in situ hybridization is a potent tool for studying IL-5 mRNA expression in Hodgkin's disease.
